Skip to main content

Table 3 Treatment responses in 59 patients

From: Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial

Treatment response

After two cycles of ICT

No. (%)

After CRT

No. (%)

Three months after CRT

No. (%)

Complete response (CR)

8/59(13.6)

47/59(79.7)

51/59(86.4)

Partial response (PR)

44/59(74.6)

12/59(20.3)

2/59(3.4)

Stable disease (SD)

4/59(6.8)

0/59(0)

0/59(0)

Not available

3/59(5.1)

0/59(0)

6/59(10.2)

Objective response (CR + PR)

52/59(88.1)

59/59(100)

53/59(89.8)

95% CI of ORR

(0.77, 0.95)

NA

(0.82, 0.98)

  1. Abbreviation ICT induction chemotherapy; CRT concurrent chemoradiotherapy; CI confidence interval; ORR objective response rate; NA not available